DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Curis Lifesciences Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·19 Aug 2026, 1:41 pm

Curis Lifesciences

Curis Lifesciences Limited has informed the stock exchanges that it has successfully obtained a certificate for the quarter ending June 30, 2026. This document confirms that the company has complied with SEBI's regulations regarding the maintenance of its shareholding data by its Depository Participants. It is a standard regulatory filing required for all listed entities to ensure transparency in their shareholding structure.

For investors, this news is largely procedural and does not indicate any operational changes or financial distress. It serves as a confirmation that the company is maintaining accurate records of its shareholding pattern. This routine compliance is essential for the smooth functioning of the securities market and helps maintain trust in the company's disclosures.

Investors should view this as a routine administrative update rather than a signal for market movement. There are no immediate implications for the company's business operations or stock price. The focus should remain on the company's core business performance and future growth plans.